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In their vertebrate hosts, arboviruses such as Semliki Forest virus (SFV) (Togaviridae) generally counteract
innate defenses and trigger cell death. In contrast, in mosquito cells, following an early phase of efficient virus
production, a persistent infection with low levels of virus production is established. Whether arboviruses
counteract RNA interference (RNAi), which provides an important antiviral defense system in mosquitoes, is
an important question. Here we show that in Aedes albopictus-derived mosquito cells, SFV cannot prevent the
establishment of an antiviral RNAi response or prevent the spread of protective antiviral double-stranded
RNA/small interfering RNA (siRNA) from cell to cell, which can inhibit the replication of incoming virus. The
expression of tombusvirus siRNA-binding protein p19 by SFV strongly enhanced virus spread between cultured
cells rather than virus replication in initially infected cells. Our results indicate that the spread of the RNAi
signal contributes to limiting virus dissemination.
In animals, RNA interference (RNAi) was first described for
Caenorhabditis elegans (27). The production or introduction of
double-stranded RNA (dsRNA) in cells leads to the degrada-
tion of mRNAs containing homologous sequences by se-
quence-specific cleavage of mRNAs. Central to RNAi is the
production of 21- to 26-nucleotide small interfering RNAs
(siRNAs) from dsRNA and the assembly of an RNA-induced
silencing complex (RISC), followed by the degradation of the
target mRNA (23, 84). RNAi is a known antiviral strategy of
plants (3, 53) and insects (21, 39, 51). Study of Drosophila
melanogaster in particular has given important insights into
RNAi responses against pathogenic viruses and viral RNAi
inhibitors (31, 54, 83, 86, 91). RNAi is well characterized for
Drosophila, and orthologs of antiviral RNAi genes have been
found in Aedes and Culex spp. (13, 63).
Arboviruses, or arthropod-borne viruses, are RNA viruses
mainly of the families Bunyaviridae, Flaviviridae, and Togaviri-
dae. The genus Alphavirus within the family Togaviridae con-
tains several mosquito-borne pathogens: arboviruses such as
Chikungunya virus (16) and equine encephalitis viruses (88).
Replication of the prototype Sindbis virus and Semliki Forest
virus (SFV) is well understood (44, 71, 74, 79). Their genome
consists of a positive-stranded RNA with a 5 cap and a 3
poly(A) tail. The 5 two-thirds encodes the nonstructural
polyprotein P1234, which is cleaved into four replicase pro-
teins, nsP1 to nsP4 (47, 58, 60). The structural polyprotein is
encoded in the 3 one-third of the genome and cleaved into
capsid and glycoproteins after translation from a subgenomic
mRNA (79). Cytoplasmic replication complexes are associated
with cellular membranes (71). Viruses mature by budding at
the plasma membrane (35).
In nature, arboviruses are spread by arthropod vectors (pre-
dominantly mosquitoes, ticks, flies, and midges) to vertebrate
hosts (87). Little is known about how arthropod cells react to
arbovirus infection. In mosquito cell cultures, an acute phase
with efficient virus production is generally followed by the
establishment of a persistent infection with low levels of virus
production (9). This is fundamentally different from the cyto-
lytic events following arbovirus interactions with mammalian
cells and pathogenic insect viruses with insect cells. Alphavi-
ruses encode host response antagonists for mammalian cells
(2, 7, 34, 38).
RNAi has been described for mosquitoes (56) and, when
induced before infection, antagonizes arboviruses and their
replicons (1, 4, 14, 15, 29, 30, 32, 42, 64, 65). RNAi is also
functional in various mosquito cell lines (1, 8, 43, 49, 52). In the
absence of RNAi, alphavirus and flavivirus replication and/or
dissemination is enhanced in both mosquitoes and Drosophila
(14, 17, 31, 45, 72). RNAi inhibitors weakly enhance SFV
replicon replication in tick and mosquito cells (5, 33), posing
the questions of how, when, and where RNAi interferes with
alphavirus infection in mosquito cells.
Here we use an A. albopictus-derived mosquito cell line to
study RNAi responses to SFV. Using reporter-based assays, we
demonstrate that SFV cannot avoid or efficiently inhibit the
establishment of an RNAi response. We also demonstrate that
the RNAi signal can spread between mosquito cells. SFV can-
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not inhibit cell-to-cell spread of the RNAi signal, and spread of
the virus-induced RNAi signal (dsRNA/siRNA) can inhibit the
replication of incoming SFV in neighboring cells. Further-
more, we show that SFV expression of a siRNA-binding pro-
tein increases levels of virus replication mainly by enhancing
virus spread between cells rather than replication in initially
infected cells. Taken together, these findings suggest a novel
mechanism, cell-to-cell spread of antiviral dsRNA/siRNA, by
which RNAi limits SFV dissemination in mosquito cells.
MATERIALS AND METHODS
Cells and viruses. A. albopictus-derived U4.4 cells were grown at 28°C in L-15
medium–10% fetal calf serum–8% tryptose phosphate broth. BHK-21 cells were
grown in Glasgow minimum essential medium–10% newborn calf serum–10%
tryptose phosphate broth (37°C in a 5% CO2 atmosphere), unless otherwise
stated. For all RNAi experiments described below, BHK-21 cells were kept in the
same medium and at the same temperature as U4.4 cells for transfection and
downstream experiments. The SFV4 strain or derived recombinant SFV was
grown in BHK-21 cells in Glasgow minimum essential medium–2% newborn calf
serum (37°C in a 5% CO2 atmosphere). Details of reporter viruses used can be
obtained from the authors. The production of SFV-derived virus-like particles
(VLPs) was previously described (57). Viruses or VLPs were purified from
supernatant by centrifugation (three times for 30 min at 15,000 rpm), concen-
trated on a 20% (wt/vol) sucrose–TNE buffer (50 mM Tris-HCl, 100 mM NaCl,
0.1 mM EDTA [pH 7.4]) cushion by ultracentrifugation (25,000 rpm for 90 min),
and resuspended in TNE buffer. Virus was titrated by plaque assay on BHK-21
cells, and VLPs were titrated by indirect immunofluorescence and quantification
of infected cells using anti-nsP3 antibody.
Plasmids and siRNA. Plasmid pRL-CMV (Promega) encodes Renilla lucifer-
ase (RLuc) under the control of the cytomegalovirus immediate-early promoter,
which is active in mosquito cells (48). siRNAs for RLuc and negative control
siRNA (siRNA 1) were obtained from Ambion (catalog numbers AM4630 and
AM4635); other negative control siRNAs were found to be similar to the latter.
Block-iT fluorescent siRNA (catalog number 2013; Invitrogen) is labeled with
fluorescein.
dsRNA production. Long dsRNA of approximately 600 bp was produced using
the MegascriptRNAi kit (Ambion). PCR products encoding a T7 promoter at
each end and spanning the RLuc and enhanced green fluorescent protein
(eGFP) genes from the start codon on were produced using primer pairs
T7dsRenFD/RE (TAATACGACTCACTATAGGGATGACTTCGAAAGTTT
ATGATCCAG/TAATACGACTCACTATAGGGCTGCAAATTCTTCTGGT
TCTAACTTTC) and dsT7eGFPFD/RE (TAATACGACTCACTATAGGGAT
GGTGAGCAAGGGCGAGGAGCTGTTC/TAATACGACTCACTATAGGG
CTGGGTGCTCAGGTAGTGGTTGTCGGGC) and pRL-CMV or pEGFP-N1
as templates, respectively. dsRNA was purified and aliquoted before use.
Transfection and cell contact experiments. A total of 1.8 105 to 2 105 U4.4
(or 1.5  105 BHK-21) cells/well were grown in 24-well plates. Before transfec-
tion, medium was replaced by fresh complete medium. DNA (20 ng) and/or
siRNA (final concentration of 5 or 10 nM)/dsRNA (5 ng) was mixed with 1
l/well Lipofectamine 2000 (Invitrogen) in Optimem according to the manufac-
turer’s instructions. One hundred microliters of the nucleic acid-Lipofectamine
2000 complexes was added to 400 l of medium in each well and incubated for
5 h at 28°C. After transfection, cells were washed twice to remove liposomes, and
complete medium was added. For contact experiments to analyze cell-to-cell
spread of RNAi using reporter genes, approximately 106 U4.4 (or BHK-21)
cells/well (six-well plates) were transfected with DNA (80 ng) or siRNA (final
concentration, 5 nM) using 1 l/well Lipofectamine 2000 for 5 h. Where indi-
cated, SFV infection was carried out prior to siRNA transfection. At 5 h post-
transfection, cells were scraped and mixed (two times; 1.5  105 or 1.5  104
cells/well for a high or low density of cells, respectively) in 24-well plates. Cells
were lysed at 24 h postmixing. For contact experiments using SFV replicon- and
virus-infected cells, the same cell numbers as described above were mixed for
high and low densities. To mix BHK and U4.4 cells at a high density, 1.5  105
cells of each cell type were added per well. A flow chart of these experiments is
shown is Fig. 1A and B.
Electroporation of mosquito cells. To electroporate DNA, 2  107 U4.4 cells
were resuspended in 800 l ice-cold phosphate-buffered saline (PBS) and mixed
with 500 ng pRL-CMV. Four hundred fifty microliters of the cell-DNA mixture
was then pipetted into a 4-mm electroporation cuvette and pulsed twice (300 V
with a pulse length of 4 ms and a pulse interval of 5 s) in a Bio-Rad electropo-
FIG. 1. Flow charts for cell mixing and scrape-loading experiments
involving U4.4 mosquito cells. (A) Mixing of transfected cells. (B) Mix-
ing of infected cells. (C) Scrape loading of fluorescein-labeled siRNA
into cells. Experimental details such as cell numbers, etc., are de-
scribed in Materials and Methods.
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rator (Genepulser Xcell with CE module). Electroporated cells were then trans-
ferred into fresh complete medium and allowed to recover for 5 h; dead cells
were removed.
Scrape loading of siRNA. The introduction of macromolecules via scrape
loading was described previously (37, 59). For scrape loading of siRNA, six-well
plates were seeded with 6.5  105 U4.4 cells/well and incubated at 28°C for 24 h.
Cells were then scraped into 1 ml of fresh complete cell culture medium in a
sterile round-bottom tube (catalog number 352054; BD Falcon), and fluorescein-
labeled Block-iT siRNA (catalog number 2013; Invitrogen) was immediately
added to a final concentration of 50 nM for 5 h at 28°C; membrane damage seals
within less than 1 min (discussed in reference 26), leaving enough time for cells
to recover. Cells were then centrifuged (5 min at 1,500 rpm), washed twice,
resuspended in 1 ml of fresh complete medium, and counted. A total of 105
scrape-loaded cells were mixed with 106 nonfluorescent, fresh U4.4 cells in a total
volume of 1 ml and seeded onto sterile coverslips in six-well plates. Cells were
incubated at 28°C for 1 or 6 h and fixed in 10% neutral buffered formalin (catalog
number 00600E; Surgipath Europe) for 1 h. Coverslips were then washed with
PBS, mounted, and sealed, and fluorescence was visualized (Zeiss AxioSkop
confocal microscope). Fluorescence-activated cell sorting (FACS) was performed
on a Becton Dickinson FACSCalibur apparatus; cells were scrape loaded/mixed as
described above, seeded into wells, removed from wells at 1 and 6 h postseeding,
and immediately analyzed by FACS. For each experiment, 20,000 cells were
gated, and numbers and percentages of fluorescent cells were measured. A flow
chart of these experiments is shown in Fig. 1C.
Infection. Virus or VLPs were diluted in PBS with 0.75% bovine serum
albumin; cells were infected at 28°C for 1 h and washed twice to remove any
unbound particles. Multiplicity of infection (MOI) refers to PFU for viruses and
infectious particles for VLPs. Complete medium was then added to cells. Infec-
tion efficiency was monitored by immunostaining using an anti-nsP3 antibody.
For cell contact experiments with SFV4(3H)-RLuc and SFV VLPs, approxi-
mately 6.5 105 U4.4 cells/well (in six-well plates) were infected (MOI of 10) for
the times indicated before cells were scraped and mixed at low or high densities
(as described above). Virus-spreading experiments were carried out in six-well
plates; confluent cell monolayers contained approximately 6.5  105 U4.4 cells/
well at the time of infection with MOIs as indicated.
Luciferase assays. Cells were lysed in passive lysis buffer (Promega), and RLuc
activities were measured using a dual-luciferase assay (Promega) with a GloMax
20/20 luminometer.
Real-time qPCR. Quantification of viral genome copy numbers was performed
essentially as previously described (7). Briefly, RNA was isolated from U4.4 cells
(three independent biological replicates per time point) using RNeasy (Qiagen).
RNA quantity and quality were assessed with a NanoDrop spectrophotometer
(Fisher Scientific). A total of 0.5 g of total RNA from each sample was reverse
transcribed, and each of those reactions was analyzed in triplicate by quantitative
PCR (qPCR). The reaction mix contained 0.8 M of each primer, 40 mM
deoxynucleoside triphosphates, 3 mM MgCl2, a 1:10,000 dilution of SYBR green
(Biogene Ltd.), 0.75 U Fast Start Taq (Roche Applied Science), and 2 l of
template. Tubes were heated to 94°C for 5 min, and the PCR was then cycled
through 94°C for 20 s, 62°C for 20 s, and 72°C for 20 s for 40 cycles on a
RotorGene 3000 instrument (Corbett Research). Sequences of the primers were
as follows: 5-GCAAGAGGCAAACGAACAGA-3 (SFV-nsP3-for) and 5-GG
GAAAAGATGAGCAAACCA-3 (SFV-nsP3-rev).
Immunostaining. U4.4 cells were fixed with 4% paraformaldehyde. After two
washes (always in PBS), cells were permeabilized with 0.3% Triton X-100 in PBS
for 20 min and washed twice. After blocking with CAS block (Invitrogen) (20
min), primary anti-nsP3 antibody (in CAS block; anti-nsP3 at a 1:800 dilution)
was added, followed by three washes. Incubation with secondary antibody (goat
anti-rabbit biotinylated immunoglobulin G in CAS block at a 1:750 dilution) was
followed by three washes, and streptavidin-conjugated Alexa Fluor 594 was
added. After two washes, slides were mounted with mounting medium (Vector
Laboratories), and images were acquired (Zeiss AxioSkop confocal microscope).
RESULTS
Like other arboviruses, SFV infection of cultured mosquito
cells usually begins with an acute phase of efficient virus pro-
duction between 12 and 24 h and then enters a persistent phase
during which only a few cells (1 to 2%) produce virus (22). In
this study, we used the A. albopictus-derived U4.4 cell line,
which has been shown to closely resemble infectivity in the
mosquito and has been previously used to study virus-host
interactions (19, 20, 61, 68). U4.4 cells have functional antimi-
crobial signaling pathways, and SFV4 infection starts with a
burst of virus production between 12 and 24 h postinfection
(p.i.), followed by persistent low-level virus production; infec-
tion at an MOI of 10 leads to an initial infection of all cells in
the culture (28). Thus, U4.4 cells are a good model system in
which to study SFV-mosquito cell interactions, and SFV4 dis-
plays the expected characteristics of an arbovirus in these cells.
SFV interference with siRNA-induced RNAi. Virus-induced
dsRNA, the initiator of RNAi responses, is produced in Sind-
bis virus-infected mammalian and mosquito cells (78). Simi-
larly, work in U4.4 cells infected with recombinant SFV en-
coding an nsP3-eGFP fusion protein, SFV(3F)4-eGFP (81),
indicates that at 10 and 24 h p.i., large amounts of virus-
induced dsRNA accumulates in replication complexes (not
shown).
Previous work has shown that an RNAi response induced
before infection can inhibit arbovirus replication in arthropod
cells and that alphavirus infection of arthropod cells leads to
the production of short, virus-derived siRNAs (32, 73); we also
found that to be the case in SFV-infected U4.4 cells (our
unpublished observations). To determine whether SFV infec-
tion of mosquito cells can interfere with the induction of RNAi
or an ongoing RNAi process, the activity of RLuc produced
from expression plasmid pRL-CMV in the presence of RLuc-
specific siRNA or negative control siRNA was used to quantify
RNAi activity in control and SFV4-infected U4.4 mosquito
cells.
First, we determined whether SFV4 could suppress an es-
tablished RNAi reaction. U4.4 cells were cotransfected with
RLuc reporter plasmid pRL-CMV and RLuc or negative con-
trol siRNA and infected or mock infected with SFV4 24 h later.
This timing allowed an accumulation of RLuc mRNA prior to
infection and avoided any effects of the infection on plasmid
expression. Luciferase activity was measured 24 h p.i. A strong
reduction in levels of RLuc reporter gene expression was ob-
served in cells receiving luciferase siRNA but not in cells re-
ceiving negative control siRNA. Neither luciferase expression
nor its reduction by luciferase siRNA was affected by subse-
quent SFV4 infection (Fig. 2A). We conclude that SFV4 does
not interfere with established RISC complexes.
Second, to determine if SFV4 can interfere with the induc-
tion of RNAi, U4.4 cells were transfected with RLuc reporter
plasmid, infected with SFV4 24 h later, and then transfected
with RLuc or negative control siRNAs. Luciferase activity was
measured 24 h posttransfection (Fig. 2B). The established in-
fection did not prevent silencing. We conclude that SFV4 does
not prevent the induction of RNAi, at least to non-virus-re-
lated sequences. Infection up to 6 h (to allow increased protein
expression) before siRNA transfection did not change the re-
sult (not shown).
It was previously shown that SFV-specific RNAi, established
prior to infection, can suppress virus replication (15); this was
also the case for U4.4 cells (not shown). To analyze whether
virus can interfere specifically with antiviral RNAi induced
after infection, the RLuc gene was cloned into the virus non-
structural protein open reading frame (Fig. 3A) to create
SFV4(3H)-RLuc (46). In this study, RLuc provides an easily
quantifiable indicator of virus replication, and RLuc siRNAs
should target the viral genome/mRNA for degradation. In
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vertebrate cells, reporter genes inserted into the nonstructural
open reading frame directly reflect replication levels for up to
6 h p.i. (46); however, in insect cells, where host gene expres-
sion is much less affected by SFV infection, we found that
RLuc reporter gene expression reflects virus replication and
genome RNA levels over longer periods (28) and show here
that this the case (see Fig. 9) for a minimum of 48 h p.i.
When RLuc siRNA was transfected 1 or 8 h after a high-
MOI infection (MOI of 10), the level of virus replication (as
determined by luciferase activity) at 24 h posttransfection was
decreased by approximately 75 or 50% compared to that of
control cells or cells treated with negative control siRNA (Fig.
3B). We conclude that SFV4 cannot inhibit siRNA-induced
antiviral RNAi.
SFV interference with long-dsRNA-induced RNAi. Despite
not being able to interfere with RISC formation, the above-
described experiments with preformed siRNA do not exclude
the possibility that SFV4 interferes with siRNA production, for
example, cleavage of long dsRNA into siRNAs. To assess this
possibility, experiments similar to those described above were
carried out with RLuc-encoding SFV4(3H)-RLuc and 600-bp
dsRNAs derived from RLuc or eGFP (see Materials and
Methods). As shown in Fig. 3C, the transfection of RLuc-
dsRNA but not eGFP-derived dsRNA 1 or 8 h following in-
fection of U4.4 cells with SFV4(3H)-RLuc (MOI of 10)
strongly reduced virus replication; this effect was slightly stron-
ger when dsRNA was transfected immediately p.i. Similarly,
silencing of plasmid-encoded RLuc activity by 600-bp dsRNA
was not affected by infection (not shown).
The RNAi signal can spread between mosquito cells. In
plants, the RNAi signal can spread cell to cell or through
vasculature to affect the whole plant; this is generally referred
to as non-cell-autonomous or systemic RNAi (85, 90). Some
plant viruses can antagonize systemic RNAi responses (67).
Gap junction-mediated cell-to-cell spread of an RNAi signal
has been observed in mammalian cell culture (82, 89). In in-
sects, it has been suggested that systemic RNAi can take place,
but to date, direct cell-to-cell spread has not been demon-
strated (6, 11, 24, 25). However, gap junctions and cytoplasmic
bridges are present between A. albopictus-derived cells in cul-
ture (12).
Insects do not encode RNA-dependent RNA polymerase to
amplify siRNAs, as occurs in plants during systemic RNAi, but
short-distance cell-to-cell spread (10 to 15 cells) of the RNAi
signal might not require prior amplification (85). To assess
whether an RNAi signal can spread between mosquito cells,
U4.4 cells were transfected with RLuc or negative control
siRNA. These cells were then mixed with U4.4 cells trans-
fected with pRL-CMV and plated at low (minimal contact) or
high (many contacts) densities. At low density, there were few
or no contacts between cells, whereas at high density, there
were many contacts (Fig. 4A). Low-density seeding controls
were necessary to avoid the formation of cytoplasmic bridges;
reporter gene experiments showed that RNAi remains func-
tional in cells at low density (not shown). As shown in Fig. 4B
(bottom), when the two types of cells were in contact (high
density), the RLuc siRNA-transfected cells were able to sup-
press reporter gene expression in pRL-CMV-transfected cells.
In contrast, no suppression of the RLuc reporter was observed
at low density (Fig. 4B, top). SFV4 infection for 1 h before
siRNA transfection did not inhibit cell-to-cell spread of the
RNAi signal. Extending the infection time (for up to 8 h)
before siRNA transfection (to allow viral proteins more time
to accumulate) or transfecting 600-bp dsRNA as source of
siRNAs did not change the result (not shown). Similar results
were also found with the A. albopictus-derived cell line C7-10
(not shown).
As a control for the presence of residual, nontransfected
Lipofectamine-nucleic acid complexes, U4.4 siRNA donor
cells were mixed with pRL-CMV-transfected BHK-21 cells,
and we assumed that no communication could happen be-
tween cells of vertebrate and invertebrate origins. RLuc
siRNA-mediated silencing of pRL-CMV does occur in
BHK-21 cells at 27°C (Fig. 5A). When U4.4 cells (with siRNA)
and BHK-21 cells (with pRL-CMV) were mixed at high density
to allow cell contact, no reduction in RLuc activity was ob-
FIG. 2. SFV interactions with RNAi. (A) U4.4 mosquito cells were
transfected with pRL-CMV (which expresses RLuc) (20 ng) and RLuc
or negative control (nc) siRNAs (5 nM) for 5 h and infected with SFV4
(MOI of 10) at 24 h posttransfection, and luciferase activities were
measured at 24 h p.i. (B) U4.4 mosquito cells were transfected with
pRL-CMV (20 ng), infected with SFV4 (MOI of 10) at 24 h posttrans-
fection, and then transfected with RLuc or negative control siRNAs (5
nM) for 5 h, and luciferase activities were measured 24 h posttrans-
fection. Each bar represents the mean of three replicates; error bars
indicate standard deviations. Every experiment was repeated at least
twice.
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served (Fig. 5A). To show that siRNA transfer does not rely on
damaged membranes in donor and/or recipient cells, an addi-
tional control experiment was carried out. U4.4 cells were
transfected with siRNA or reporter plasmid pRL-CMV and
then scraped and seeded at high density on attached U4.4 cells
(and therefore with intact cell membranes) previously trans-
fected with pRL-CMV or siRNA, respectively. As shown in
Fig. 5B, RLuc siRNAs successfully silenced RLuc activity. This
demonstrates that siRNAs transfer through intact cellular
membranes, and membrane damage is not relevant for siRNA
transfer.
To verify this finding using non-liposome-based methods,
U4.4 reporter cells were transfected with pRL-CMV (express-
ing RLuc) by electroporation. U4.4 cells infected with SFV-
derived VLPs (MOI of 10; infected for 24 h to allow siRNA
accumulation) were used as siRNA donor cells. VLPs contain
the virus genome coding sequences required for RNA replica-
tion, the replicon, but have the virus structural coding se-
quences deleted; they can efficiently infect cells, but VLP-
infected cells cannot generate new virions. VLPs containing
three different replicons were used: SFV(nseGFP/H)1 (as a
control) had eGFP inserted between duplicated nsP2 cleavage
sites in the nsP3/4 junction region, SFV(nseGFP/H)1-RLucAS
had RLuc cloned in the antisense orientation (RLucAS)after
the subgenomic promoter, and SFV(nseGFP/H)1-p19-RLucAS
expressed the siRNA-binding protein p19 and RLucAS from a
double-subgenomic promoter (Fig. 6A). Silencing by antisense
gene expression in mosquito cells infected with SFV replicons
was previously described to inhibit superinfection with Rift
Valley fever virus (4), and the expression of antisense RLuc
allows the production of RLuc siRNAs without generating
luciferase activity. The well-characterized plant tombusvirus
RNAi inhibitor p19 (75) specifically binds to siRNAs and was
previously shown to function in Drosophila embryo extracts
(50). The siRNA-binding activity is a property of the p19 pro-
tein, and p19 RNAs display no biological activity (66, 80); we
did not detect any effects of full-length or truncated p19-de-
rived dsRNAs on reporter gene silencing (not shown). The
reporter U4.4 cells were mixed shortly after electroporation
(with pRL-CMV) with donor cells (infected 24 h earlier with
VLPs) and incubated for 24 h. As shown in Fig. 6B, contact
with siRNA donor cells infected with RLucAS VLPs resulted
in a significant decrease (P 0.0001 by paired t test) of 20% in
luciferase activity in reporter cells; this was rescued by express-
ing the siRNA-binding protein p19 in the donor cells. These
results are consistent with those obtained using Lipofectamine-
based studies (Fig. 4) and indicate that the cell-to-cell transfer
of siRNA can inhibit gene expression in reporter cells.
Scrape loading of siRNA into mosquito leads to spread
of fluorescein-labeled siRNA. As U4.4 cells do not take up
siRNAs if simply added to the cells (our unpublished observa-
tions), we also verified that cell-to-cell spread of siRNA was
occurring using a fluorescein-labeled siRNA (Block-iT fluores-
cent oligonucleotide; Invitrogen). Scraping of cells (see Mate-
rials and Methods for details) results in damaged membranes
through which macromolecules such as RNA can be taken up.
U4.4 mosquito cells were scraped from plastic dishes using a
cell scraper and immediately incubated with fluorescein-la-
beled siRNA. These cells were then washed, counted, mixed
with fresh U4.4 cells at a ratio of 1:10, seeded onto coverslips,
and fixed after 1 h (to allow cell attachment and recovery of
normal morphology) or 6 h. Total cell numbers and the num-
FIG. 3. SFV interactions with antiviral RNAi. (A) SFV4(3H)-RLuc encodes RLuc (flanked by duplicated nsP2-protease cleavage sites at the
nsP3/4 junction) as part of the viral nonstructural polyprotein. (B) Transfection of RLuc but not negative control (nc) siRNA (10 nM) of U4.4
mosquito cells with SFV4(3H)-RLuc (MOI of 10) at 1 or 8 h p.i. strongly reduced virus replication. RLuc activities were determined at 24 h
posttransfection. NTC, nontransfected control. (C) SFV fails to inhibit cleavage of dsRNA. Transfection of RLuc dsRNA but not eGFP-derived
dsRNA (5 ng/well) of approximately 600 bp of U4.4 mosquito cells with SFV4(3H)-RLuc (MOI of 10) at 1 or 8 h p.i. strongly reduced virus
replication. dsRNAs were derived from RLuc or control eGFP (see Materials and Methods); RLuc activities were determined at 24 h posttrans-
fection. Each bar represents the mean of three replicates; error bars indicate standard deviations. Every experiment was repeated at least twice.
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bers of fluorescent cells per field were determined (Fig. 7A).
While cell numbers remained the same at 1 and 6 h postmixing,
there was a significant (P  0.0001 by paired t test) increase of
40 to 60% in fluorescent cells (Fig. 7A). A similar experiment
was performed to quantify the increase in fluorescent cells
from 1 to 6 h post-scrape loading by FACS (described in
Materials and Methods). As shown in Fig. 7B, a similar in-
crease in the number of fluorescent cells was observed. This
shows that siRNA can spread between U4.4 cells.
Spread of dsRNA/siRNA between mosquito cells inhibits
SFV replication. Next, we determined whether cell-to-cell
spread of the RNAi signal in mosquito cells was able to affect
virus replication. RNAi donor cells were prepared by infecting
U4.4 cells with SFV(nseGFP/H)1 VLPs (MOI of 10; control).
VLPs were not found to induce the synthesis of secreted an-
tiviral activities. After 24 h to allow SFV replicon-derived
dsRNAs and siRNAs to accumulate (and when SFV superin-
fection exclusion is established) (our observations), VLP-in-
fected or noninfected donor cells were mixed with U4.4 cells
freshly infected (1 h p.i.) with SFV4(3H)-RLuc (Fig. 3A) (re-
porter cells) at low or high density (as described above). As
shown in Fig. 8A, at 24 h postmixing, in low-density cultures
with minimal or no cell-to-cell contact, relative to the nonin-
fected control (NIC) donor cells, the VLP-infected donor cells
did not suppress virus replication, as determined by RLuc
activity in the reporter cells. In contrast (Fig. 8A), virus repli-
cation was strongly inhibited (relative to that of the NIC) when
the reporter cells were in close contact (“many contacts”) with
siRNA donor cells. An additional experiment was performed
to verify that the suppression signal generated from the donor
cells involved RNAi. Donor cells were infected with SFV VLPs
in which the replicons also expressed the influenza virus NS1
protein under the control of the SFV subgenomic promoter
[SFV(nseGFP/H)1-NS1]. The NS1 protein functions as an
RNAi inhibitor in arthropod cells, binding both siRNA and
longer dsRNA (10, 33, 56). After 24 h (to allow SFV replicon-
derived dsRNAs and siRNAs to accumulate), NS1-expressing
VLP-infected donor cells were mixed with U4.4 cells infected
1 h previously with SFV4(3H)-RLuc (reporter cells) at low or
high density (as described above). As shown in Fig. 8A, at 24 h
postmixing, in low-density cultures with minimal cell-to-cell
contact relative to noninfected donor cells (NIC), the NS1-
expressing VLP-infected dsRNA/siRNA donor cells did not
affect replication of the reporter virus in the reporter cells. In
contrast, virus replication was rescued by about 50% relative to
that of donor cells infected with VLPs not expressing NS1
(control), when the reporter cells were in close contact (“many
contacts”) with donor cells infected with the NS1-expressing
SFV replicon (Fig. 8A).
The NS1 protein is multifunctional in vertebrate cells, and in
FIG. 4. Spread of RNAi signal between mosquito cells. U4.4 mosquito cells were transfected with pRL-CMV (expressing RLuc) or transfected
with siRNAs (RLuc or negative control [nc]) (5 nM) or first infected with SFV4 (MOI of 10) and then transfected with siRNAs. This was followed
by cell mixing. (A) Phase-contrast microscopy showing U4.4 cells mixed at low density (minimal contact [top]) or high density (many contacts
[bottom]). (B) RNAi in cultures with minimal (top) or many (bottom) cell-to-cell contacts and effect of SFV4 infection on spread of RNAi signal
to U4.4 cells transfected with reporter plasmid pRL-CMV. RLuc activities were determined 24 h after cell mixing. Dotted line, background. Each
bar represents the mean of three replicates; error bars indicate standard deviations. Every experiment was repeated at least twice.
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the above-described system, reporter cells are infected with
virus capable of spreading between reporter cells. While we
have not detected an induction of mosquito signaling pathways
by dsRNA (our unpublished observations) or SFV itself (28),
we had to exclude any secondary effects of NS1 or replicating
virus. A similar experiment was therefore performed with SFV
VLPs containing control SFV(nseGFP/H)1 or SFV(nseGFP/
H)1-p19 replicons as an siRNA donor. Twenty-four hours p.i.
(to let replicon-derived siRNAs accumulate), siRNA donor
U4.4 cells were mixed with U4.4 reporter cells freshly infected
(1 h p.i.) with SFV(RLuc/H)1 VLPs (SFV replicon expressing
RLuc instead of eGFP, as described in the legend of Fig. 6A).
At 24 h postmixing, in low-density U4.4 cultures with minimal
cell-to-cell contact relative to NIC, the VLP-infected dsRNA/
siRNA donor cells did not suppress virus replication, as deter-
mined by RLuc activity in the reporter cells. However, virus
replication in reporter cells was rescued again by about 50%
relative to that in donor cells infected with a replicon not express-
ing p19 when the reporter cells were in close contact (“many
contacts”) with donor cells enriched in dsRNAs and siRNAs
derived from the p19-expressing SFV replicon (Fig. 8B).
To directly analyze the effect of replicon-induced, spreading
siRNA on SFV production, we carried out an experiment sim-
ilar to that described in the legend of Fig. 8B, when cells were
in close contact (“many contacts”). U4.4 mosquito cells were
noninfected (NIC) or infected (MOI of 10) with SFV VLPs
containing control SFV(nseGFP/H)1 or SFV(nseGFP/H)1-
p19 replicons as siRNA donors. At 24 h p.i. (to let replicon-
derived siRNAs accumulate), siRNA donor U4.4 cells were
mixed with U4.4 reporter cells freshly infected (1 h p.i.) with
SFV4 (MOI of 1). Virus production from SFV4-infected re-
porter cells was completely rescued (more than a 10-fold in-
crease, similar to NIC donor cell levels) relative to donor cells
infected with a replicon not expressing p19 when the reporter
cells were in close contact (“many contacts”) with donor cells
enriched in dsRNAs and siRNAs derived from the p19-ex-
pressing SFV replicon (Fig. 8C).
Together, these studies show that the donor cell-derived
FIG. 5. Spread of RNAi signal is specific and does not require membrane damage. (A, left) Silencing of RLuc activity in BHK-21 cells
(incubated at 28°C) transfected with 20 ng pRL-CMV and siRNAs (5 nM). (Right) Absence of RLuc silencing by RNAi in BHK-21 cells (incubated
as described above) transfected with 20 ng pRL-CMV and mixed with U4.4 cells previously transfected with siRNAs (RLuc or negative control
[nc]) (5 nM). NTC, nontransfected control. (B) U4.4 mosquito cells transfected with pRL-CMV (20 ng) (left) or siRNA (RLuc or negative control
[nc]) (5 nM) (right) were scraped and then seeded at high density onto U4.4 cells attached to the dish surface and previously transfected with
siRNA (left) or pRL-CMV (right), respectively. RLuc activities were determined 24 h after cell mixing. Each bar represents the mean of three
replicates; error bars indicate standard deviations. Every experiment was repeated at least twice.
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signal is RNAi based and that it can spread from cell to cell to
inhibit virus replication.
Viral expression of an siRNA-binding protein strongly en-
hances virus spread through cultured cells. Given the above-
described findings, we wanted to know whether the spread of
FIG. 6. SFV-induced siRNA spread between U4.4 mosquito cells.
(A) Replicons used to produce VLPs. eGFP was inserted between
duplicated nsP2 cleavage sites in the nsP3/4 junction region of the
nonstructural open reading frame. (B) RLuc expression plasmid pRL-
CMV was electroporated into U4.4 cells (reporter cells), which were
then mixed at a low density (minimal contact [top]) or high density
(many contacts [bottom]) with U4.4 cells infected for 24 h with the
VLPs SFV(nseGFP/H)1 (control replicon [CTRL]), SFV(nseGFP/
H)1-RLucAS, or SFV(nseGFP/H)1-p19-RLucAS to allow siRNA ac-
cumulation (donor cells). RLuc activities were determined at 24 h
postmixing. Dotted line, background. Each bar represents the mean of
three replicates; error bars indicate standard deviations. Every exper-
iment was repeated at least twice.
FIG. 7. Scrape loading of siRNA and spread of fluorescein-labeled
siRNA (Block-iT fluorescent oligonucleotide; Invitrogen). Scraping of
cells from the surface using a cell scraper briefly results in damaged
membranes through which RNA can be taken up (see Materials and
Methods). U4.4 mosquito cells were scraped from the dish surface and
immediately incubated with fluorescein-labeled siRNA for 5 h; scrape-
loaded cells were then washed, counted, mixed with fresh U4.4 cells at
a ratio of 1:10, and plated onto coverslips (A) or into wells (B).
(A) Cells were fixed at 1 h (to allow cell attachment and recovery of
normal morphology) and 6 h postplating; total cell numbers (top) and
numbers of fluorescent cells (bottom) per field were counted (at mag-
nifications of 40 [10 fields] and 20 [15 fields], respectively). (B) Al-
ternatively, cells seeded into wells (in triplicate for each time point)
were scraped and immediately analyzed by FACS; for each data point,
20,000 cells were gated, and fluorescent cells were counted. Numbers
of fluorescent cells at 1 and 6 h postmixing are indicated. Bars repre-
sent the means, and error bars indicate standard deviations. Every
experiment was repeated at least twice.
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FIG. 8. Spread of the RNAi signal between cells results in antiviral activity. Parallel cultures of U4.4 mosquito cells were noninfected (NIC)
(A and B) or infected (MOI of 10) with VLPs containing the SFV replicons SFV(nseGFP/H)1 (control replicon [CTRL]) (A and B), SFV(nseGFP/
H)1-NS1 (A), or SFV(nseGFP/H)1-p19 (B) and then incubated for 24 h to allow replicon-derived dsRNA/siRNA accumulation in donor cells.
Replicons express eGFP from the nonstructural region (as described in the legend of Fig. 6) and no additional protein (control), influenza virus
NS1 (dsRNA/siRNA-binding RNAi inhibitor in arthropod cells), or tombusvirus p19 (siRNA-binding protein) from the subgenomic promoter.
After 24 h, replicon-containing or noninfected cells were mixed with U4.4 cells freshly infected (1 h p.i.) with RLuc-encoding SFV4(3H)-RLuc virus
(A) or SFV(RLuc/H)1 VLPs (B) (MOI of 10) (reporter cells) at low (minimal contact) or high (many contacts) density. RLuc activity (indicating
replication of virus) was measured 24 h postmixing. (C) Cell-to-cell spread of siRNA inhibits SFV4 production. U4.4 mosquito cells were
noninfected (NIC) or infected (MOI of 10) with VLPs containing SFV replicons (as described above), SFV(nseGFP/H)1 (control replicon), or
SFV(nseGFP/H)1-p19 and then incubated for 24 h to allow replicon-derived dsRNA/siRNA accumulation in donor cells. After 24 h, replicon-
containing or noninfected donor cells were mixed with U4.4 cells freshly infected (1 h p.i.) with SFV4 (MOI of 1) at high density (many contacts).
SFV4 production at 12 and 24 h postmixing is shown; virus titers (PFU/ml) were determined by plaque assay (as described in Materials and
Methods). Each bar represents the mean of three replicates; error bars indicate standard deviations. Every experiment was repeated at least twice.
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the RNAi signal is important in limiting virus dissemination in
mosquito cells. Studies with arbovirus-derived replicons show
that the expression of RNAi inhibitors had weak enhancing
effects on replication (5, 33). Previous work has also shown that
antiviral RNAi restricts the spread of O’nyong-nyong and
Sindbis alphaviruses into mosquito tissues (14, 45); however,
the mechanisms involved remain unclear: a secondary effect of
enhanced replication/virus production in initially infected cells,
enhanced dissemination of virus, differential RNAi responses
in tissues, or a combination of these factors is a possibility. To
analyze the link between virus dissemination and cell-to-cell
spread of the RNAi signal, we studied SFV4 expressing the
siRNA-binding tombusvirus protein p19.
p19 was inserted into an RLuc-encoding SFV after a dupli-
cated subgenomic promoter, placed after the structural region
to create SFV4(3H)-RLuc-p19 (Fig. 9A). The replication of
FIG. 9. Replication of SFV encoding an RNAi inhibitor. (A) RLuc reporter SFV expressing tombusvirus siRNA-binding protein p19 from a
duplicated subgenomic promoter [SFV4(3H)-RLuc-p19]. (B) Confluent U4.4 cells were infected at an MOI of 1 with SFV4(3H)-RLuc (Fig. 3) or
SFV4(3H)-RLuc-p19 and transfected with RLuc or negative control (nc) siRNAs (concentration of 10 nM) for 5 h at 8 h p.i. RLuc activities were
measured 24 h posttransfection. Results are expressed as a percentage of the control value (nontransfected, infected U4.4 cells [dotted line]).
(C) Confluent U4.4 mosquito cells were infected at a high MOI (MOI of 10) or low MOI (MOI of 0.001) with SFV4(3H)-RLuc-p19 or
SFV4(3H)-RLuc. Cells were lysed at 48 h p.i., and RLuc activities were determined. High MOI mimics initial infection as all cells are infected, while
low MOI allows the virus to spread through the monolayer and undergo multiple rounds of infection. (D) Infection of U4.4 mosquito cells with
SFV4(3H)-RLuc or SFV4(3H)-RLuc-p19 at high MOI (MOI of 10) or low MOI (MOI of 0.001). RNA was extracted at 48 h p.i., and virus genome
copy numbers were determined by real-time qPCR (targeting a region of nsP3 as described in Materials and Methods). (E) U4.4 mosquito cells
were infected with SFV4(3H)-RLuc or SFV4(3H)-RLuc-p19 at high MOI (MOI of 10) or low MOI (MOI of 0.001). Virus production (PFU/ml)
was measured at 6, 24, and 48 h p.i. by plaque assay titration of supernatants (as described in Materials and Methods). F, SFV4(3H)-RLuc-p19;
E, SFV4(3H)-RLuc. Each bar represents the mean of three replicates (with the exception of real-time qPCR, where more replicates were analyzed)
(see Materials and Methods); error bars indicate standard deviations. Every experiment was repeated at least twice.
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SFV4(3H)-RLuc but not of SFV4(3H)-RLuc-p19 was inhibited
by antiviral siRNAs (Fig. 9B). In subsequent experiments, con-
fluent cultures of U4.4 mosquito cells were infected with
SFV4(3H)-RLuc-p19 or SFV4(3H)-RLuc at a high MOI (MOI
of 10) or a low MOI (MOI of 0.001) and lysed at 48 h p.i., and
RLuc activities (replication readout) were determined (Fig.
9C). Following high-MOI infection, in which all cells were
infected synchronously, the level of virus replication was only
slightly increased with p19 expression. Following low-MOI in-
fection, however, which allows rounds of virus infection and
spread, p19-encoding virus replicated far more efficiently than
control virus (20-fold increase); similar results were also found
with the A. albopictus-derived cell line C7-10 (not shown). No
cytopathic effect or change in cell numbers was observed at
either high- or low-MOI infection (not shown).
Real-time qPCR was used to quantify viral genomes. At
48 h p.i., as shown in Fig. 9D, at a high MOI (MOI of 10),
genome levels in SFV4(3H)-RLuc or SFV4(3H)-RLuc-p19
are similar, while infection at a low MOI (0.001) leads to an
accumulation of SFV4(3H)-RLuc-p19 genome RNA (ap-
proximately a sixfold increase). In addition, in U4.4 cells
infected at a high MOI (MOI of 10), virus production by
SFV4(3H)-RLuc-p19 was similar or approximately eightfold
increased (at 48 h p.i.) in comparison to that of SFV4(3H)-
RLuc, while low-MOI (MOI of 0.001) infection leads to an
important production of SFV4(3H)-RLuc-p19 [50-fold in-
crease at 48 h p.i. compared to SFV4(3H)-RLuc, which is
rapidly inhibited] (Fig. 9E). These results also demonstrate
the accuracy of RLuc as a readout for virus replication and
genome RNA levels.
To visualize virus spread directly by immunofluorescence,
U4.4 cells were infected at a high MOI (MOI of 10) or low
MOI (MOI of 0.001) with SFV4(3H)-RLuc or SFV4(3H)-
RLuc-p19, and cells were fixed at 24 p.i. SFV replication
complexes were stained using an anti-nsP3 antibody (28). As
shown in Fig. 10, low-MOI infection with SFV4(3H)-RLuc-
p19 leads to the rapid infection of many cells within the cell
monolayer at 24 h p.i. In contrast, very few cells are infected
by spreading SFV4(3H)-RLuc. As expected, all cells are
infected following high-MOI infection by either virus. These
data confirm results obtained with RLuc as a replication
readout.
FIG. 10. Visualization of SFV spread. U4.4 mosquito cells were infected with SFV4(3H)-RLuc (A and B) or SFV4(3H)-RLuc-p19 (C and D)
at a high MOI (MOI of 10) (A and C) or low MOI (MOI of 0.001) (B and D). Cells were fixed at 24 h p.i. and stained with an anti-nsP3 antibody
(as described in Materials and Methods). Representative sections of cells are shown; selected replication complexes (bright focal staining) are
indicated by arrows.
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DISCUSSION
In this paper, we show that SFV cannot avoid or efficiently
inhibit the establishment of nonviral or antiviral RNAi re-
sponses and that the generation of an antiviral RNAi response
effectively suppresses virus replication. Even though RNAi is
known to limit arbovirus replication, observations of Sindbis
virus-infected A. aegypti mosquitoes suggest that the knock-
down of genes involved in RNAi did not result in increased
mortality rates (14). However, it has recently been shown
that infection of A. aegypti mosquitoes with Sindbis and
O’nyong-nyong alphaviruses encoding flock house virus B2
protein (an RNAi suppressor which binds long dsRNA as
well as siRNA) led to a decreased rate of survival of mos-
quitoes (62). This suggests that RNAi is crucial for main-
taining the balance between vector survival and virus repli-
cation and transmission.
Previous findings by others and by us showed that SFV
replicon replication in arthropod cells is inhibited if RNAi is
induced before infection and induces the production of virus-
derived siRNAs and that replication is weakly enhanced by the
expression of RNAi inhibitors (such as the dsRNA-binding
protein NS1) (5, 15, 32, 33). This study extends these findings
and, as the virus is sensitive to RNAi, supports the hypothesis
that arboviruses do not encode generally active RNAi inhibi-
tors (55), with the possible exception of plant-infecting arbo-
viruses (41). We also show that SFV cannot, or cannot effi-
ciently, interfere with antiviral RNAi induced p.i.; this is
different from siRNA resistance reported previously after
West Nile flavivirus infection of mammalian cells (36).
While virus strain-specific differences have been observed in
mosquitoes infected with the closely related Sindbis virus (14),
virus-derived siRNAs seem to be a common feature of alpha-
virus infection of arthropod cells (32, 73), and our results show
that SFV fails to inhibit the cleavage of long dsRNA into
biologically active siRNAs (Fig. 3C). This is unlike pathogenic
insect viruses, such as flock house virus or Drosophila C virus,
which encode RNAi suppressors (39, 53). Importantly, our
results show that the RNAi signal spreads between mosquito
cells and that this can inhibit the replication of incoming SFV.
This effect can be inhibited by expressing dsRNA/siRNA-bind-
ing proteins, confirming the nature of the spreading RNAi
signal. In the mosquito, spread of the RNAi signal is likely to
curtail virus dissemination. Some plant viruses specifically in-
hibit systemic RNAi (67). Short-distance cell-to-cell spread
would not require cellular RNA-dependent RNA polymerase,
which is absent in mosquito cells (43, 85). Similar cell-to-cell
spread seems to be absent in Drosophila melanogaster, al-
though short-distance cell-to-cell spread of the RNAi signal
might not be easily observed in an entire organism (69). Inter-
estingly, experiments with p19-expressing SFV show that while
there is little enhancing effect of the siRNA-binding protein on
replication at a high MOI (mimicking initially infected cells, as
all cells in the culture are infected), the enhancing effects of
p19 (derived from plant-infecting tombusvirus) are strong at a
low MOI, where the virus is allowed rounds of infection and
spreads through the U4.4 cell monolayer. In plants, the main
role of Cymbidium ringspot tombusvirus p19 is not to prevent
siRNA/RISC complex assembly by siRNA binding in initially
infected cells but to facilitate virus spread into surrounding
tissues by inhibiting the cell-to-cell spread of siRNAs (40, 77,
80). Our cell contact experiments as well as infections at high
and low MOIs with p19-expressing SFV indicate that cell-to-
cell spread of antiviral siRNAs can inhibit the replication of
incoming virus and slows down the spread of SFV through the
mosquito cell monolayer. This defines at least one of the mech-
anisms resulting in altered alphavirus dissemination patterns in
mosquitoes when RNAi is not functional (14, 45). Whether the
cell-to-cell spread of siRNA in mosquito cell cultures involves
gap junctions or other mechanisms is currently under investi-
gation.
A recent publication suggested that efficient antiviral immu-
nity in Drosophila requires the systemic spread of the RNAi
response, based mainly on genetic data (70). Those authors
suggested a model by which long dsRNA (not siRNA) is re-
leased from infected cells and taken up by other cells in the fly
by a known receptor; mutation of this system leads to hyper-
sensitivity to virus infection. The lineages containing Drosoph-
ila and Aedes diverged 250 million years ago, are distant from
an evolutionary point of view, and show extensive diversifica-
tion in their respective immune repertoires (18, 76, 86). Unlike
Drosophila cells, Aedes cells in culture do not (to our knowl-
edge or in our experience) take up free dsRNA from medium.
We show that in cultured mosquito cells, siRNA can move
between cells that are in contact, the secretion or subsequent
uptake of dsRNA is not taking place, and spreading siRNA has
direct antiviral activity on incoming SFV. Despite functional
differences, this shows that the systemic aspect of antiviral
RNAi is important in insects.
Presumably, replication rates before the inhibition of virus
replication by RNAi are high enough to ensure virus spread
through the mosquito even in the absence of a generally active,
efficient RNAi inhibitor. Alternatively, cells within mosquito
tissues with weaker (or completely absent) RNAi responses
might continuously produce virus or at least be more permis-
sive to arbovirus replication; differential dissemination pat-
terns, as described previously by Keene et al. (45), after silenc-
ing of the RNAi machinery suggest that this could be the case.
It would be interesting to know if alphaviruses encoding RNAi
inhibitors also disseminate differently in mosquitoes (as our
results suggest spreading patterns that are different from those
of wild-type viruses), whether localized pathologies are respon-
sible for the rapid death of infected mosquitoes by cell death,
for example (as results from a recent study suggest) (62), or
whether a combination of both exists. Arboviruses such as SFV
are relatively efficiently passed on by biting of vertebrate hosts,
and high levels of virus amplification take place within one or
more vertebrate hosts. In the arthropod vector, virus levels
need only be sufficient to ensure transmission. An early phase
of high-level virus production and dissemination followed by
conversion to a low-level productive persistent infection may
achieve a sufficient level of virus without compromising vector
viability and transmission to the amplifying vertebrate host.
Indeed, a reduction in the level of virus transmission as a result
of reduced vector survival as a result of high virus titers could
act as a negative selective pressure, preventing the evolution in
arboviruses of highly efficient mechanisms to suppress host
responses, such as RNAi.
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